C-peptide also inhibits the activation of Notch1 and Jagged1 in the Notch signaling pathway and TGF-β1 in the TGF-β signaling pathway, thereby alleviating the progression of diabetic nephropathy (90). This evidence concerns the gene TGFB1 and diabetic kidney disease.